13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2014-09-30, filed 2014-11-14, with 30 holding rows worth $128,295,606.
- Accession
- 0001546927-14-000196
- Filer
- CIK 1595855
- Filed
- 2014-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2014
A holdings report, 30 entries on the cover page, a total value of $128,295,606 stated on the cover page (in dollars after the unit check, H1), rows summing to $128,295,606 with VALUE read as dollars, detected, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CHIMERIX INC COM | 16934W106 | Stock | 755,000 | $20,853,100 | dollars, detected | |
| PHARMACYCLICS INC | 716933106 | COM | 85,000 | $9,981,550 | dollars, detected | |
| RETROPHIN INC | 761299106 | COM | 1,000,000 | $9,020,000 | dollars, detected | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 1,500,000 | $8,100,000 | dollars, detected | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 113,500 | $6,963,225 | dollars, detected | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 140,000 | $6,210,400 | dollars, detected | |
| CEMPRA INC | 15130J109 | COM | 504,800 | $5,532,608 | dollars, detected | |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 550,000 | $4,933,500 | dollars, detected | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 85,000 | $4,811,000 | dollars, detected | |
| INSYS THERAPEUTICS INC | 45824V209 | COMMON STOCK | 122,500 | $4,750,550 | dollars, detected | |
| INSPIREMD INC | 45779A309 | COM | 2,088,500 | $4,594,700 | dollars, detected | |
| CODEXIS INC | 192005106 | COM | 1,690,000 | $3,937,700 | dollars, detected | |
| BIND THERAPEUTICS INC | 05548N107 | Cmn | 450,000 | $3,865,500 | dollars, detected | |
| IMPRIMIS PHARMA IMMY | 45323A201 | COMMON | 502,500 | $3,728,550 | dollars, detected | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 157,000 | $3,479,120 | dollars, detected | |
| TETRAPHASE PHARMACEUTICALS INC | 88165N105 | COMMON STOCK | 169,700 | $3,385,515 | dollars, detected | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 975,000 | $3,237,000 | dollars, detected | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 125,000 | $2,953,750 | dollars, detected | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 29,100 | $2,272,710 | dollars, detected | |
| CELGENE CORP | 151020112 | RIGHT 12/31/2030 | 660,000 | $2,237,400 | dollars, detected | |
| AEGERION PHARMACEUTICALS INC | 00767E102 | COM | 57,500 | $1,919,350 | dollars, detected | |
| Accelerate Diagnostics | 00430H102 | COM | 89,200 | $1,916,016 | dollars, detected | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 134,500 | $1,712,185 | dollars, detected | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 67,000 | $1,641,500 | dollars, detected | |
| GERON CORP | 374163103 | COM | 820,000 | $1,640,000 | dollars, detected | |
| EVOKE PHARMA INC | 30049G104 | COM | 267,000 | $1,468,367 | dollars, detected | |
| OPHTHOTECH CORP | 683745103 | COM | 35,000 | $1,362,550 | dollars, detected | |
| CELATOR PHARMACEUTICALS INC | 15089R102 | Cmn | 405,000 | $1,024,650 | dollars, detected | |
| BIOLINERX LTD-SPONS ADR | 09071M106 | SPON | 490,000 | $754,600 | dollars, detected | |
| KIPS BAY MEDICAL INC | 49726K105 | COM | 50,000 | $8,510 | dollars, detected |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001546927-14-000196 | this filing | 2014-11-14 | acceptance time not in the bulk data set |